Friday 2 October

Location: Room S3

Topic 2: NAMs – From Predictivity to Transability
08:45 - 09:30 | Keynote  - A pathologist’s role in the adoption of NAMs: Should we lead, follow, or get out of the way? - Brian R. Berridge
Bob Maronpot Guest Lecture Award - Keynote lecture is kindly sponsored by the IATP and the Telikicherla Higher Education Foundation 

09:30 - 09:50 |  Modernizing Nonclinical Safety Assessment: Weight of Evidence and NAMs - Nadine Stokar-Regenscheit
09:50 - 10:00 | Q&A1
10:00 - 10:30 |  Pathologist's toolbox for in vitro model characterization and toxicologic pathology evaluation - Nadine Stokar-Regenscheit

10:30 - 11:00 | Morning Coffee Break - Exhibition area

11:00 - 11:30 |  Example 1: From Animal Models to Human Biology: Lung, Intestinal, and Skin NAMs in Drug Discovery - Dinesh Bangari
11:30 - 11:55 |  Example 2: Leveraging Pathology to Advance New Approach Methodologies for Respiratory Toxicity Testing - James Baily
11:55 - 12:15 |  Example 3: Balancing Innovation and Evidence: Integrating In Silico, In Vitro, and In Vivo Approaches in Next-Generation Risk Assessment - David Rouquie
12:15 - 12:35 |  Example 4: Translating Nonclinical Renal Toxicity Of Novel Antibiotics Using Kidney-On-A-Chip Models And Urinary Biomarkers - Steven Laing

12:35 - 12:50 |  Example 5: Leveraging the complementary strengths of tissue cross-reactivity and cell-based protein array technologies for off-target assessment - James T Raymond
12:50 - 13:00 | Q&A2

13:00 - 13:05 | Closing Ceremony

13:05 - 14:00 | Farewell lunch - Exhibition area